Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS; ACTIV-2/A5401 Study Team; Hughes MD, Smith DM.
Chew KW, et al. Among authors: moser c.
Nat Commun. 2023 Jan 19;14(1):333. doi: 10.1038/s41467-023-35835-3.
Nat Commun. 2023.
PMID: 36658128
Free PMC article.
No abstract available.